Format

Send to

Choose Destination
Tob Control. 2018 Nov;27(Suppl 1):s13-s19. doi: 10.1136/tobaccocontrol-2018-054325. Epub 2018 Sep 11.

Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke.

Author information

1
Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA.
2
Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, San Francisco, California, USA.
3
Division of Cardiology, University of California, San Francisco, San Francisco, California, USA.
4
Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California, USA.

Abstract

BACKGROUND:

Heated tobacco products (also called 'heat-not-burn' products) heat tobacco at temperatures below that of combustion, causing nicotine and other compounds to aerosolise. One such product, IQOS from Philip Morris International, is being marketed internationally with claims of harm reduction. We sought to determine whether exposure to IQOS aerosol impairs arterial flow-mediated dilation (FMD), a measure of vascular endothelial function that is impaired by tobacco smoke.

METHODS:

We exposed anaesthetised rats (n=8/group) via nose cone to IQOS aerosol from single HeatSticks, mainstream smoke from single Marlboro Red cigarettes or clean air for a series of consecutive 30 s cycles over 1.5-5 min. Each cycle consisted of 15 or 5 s of exposure followed by removal from the nose cone. We measured pre-exposure and postexposure FMD, and postexposure serum nicotine and cotinine.

RESULTS:

FMD was impaired comparably by ten 15 s exposures and ten 5 s exposures to IQOS aerosol and to cigarette smoke, but not by clean air. Serum nicotine levels were similar to plasma levels after humans have smoked one cigarette, confirming that exposure conditions had real-world relevance. Postexposure nicotine levels were ~4.5-fold higher in rats exposed to IQOS than to cigarettes, despite nicotine being measured in the IQOS aerosol at ~63% the amount measured in smoke. When IQOS exposure was briefer, leading to comparable serum nicotine levels to the cigarette group, FMD was still comparably impaired.

CONCLUSIONS:

Acute exposures to IQOS aerosol impairs FMD in rats. IQOS use does not necessarily avoid the adverse cardiovascular effects of smoking cigarettes.

KEYWORDS:

electronic nicotine delivery devices; harm reduction; nicotine; non-cigarette tobacco products; smoking caused disease

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center